Dr Paul Brennan (BSc (Hons) MB BChir FRCS (Ed), PhD)
Reader and Honorary Consultant Neurosurgeon

- Centre for Clinical Brain Sciences
- Cancer Research UK Edinburgh Centre
- Edinburgh Neuro-Oncology
Contact details
- Email: paul.brennan@ed.ac.uk
Address
- Street
-
Centre for Clinical Brain Sciences
Chancellor's Building
49 Little France Crescent - City
- Edinburgh
- Post code
- EH16 4SB
Background
Paul is Reader and Honorary Consultant Neurosurgeon at the University of Edinburgh and NHS Lothian.
Paul's research spans the laboratory and the clinic, combining molecular, epidemiology and clinical investigation to guide rationale innovation to improve patient care. He applies this strategy to improving diagnosis, treatment and outcomes for people with brain tumours, and traumatic brain or spinal injuries. As founder of University of Edinburgh spin-out, eoSurgical Ltd, he has also led innovation in surgical simulation training around the world.
In the laboratory he probes mechanistic hypotheses generated by using large scale clinical data to drive discovery science. He collaborates on bringing innovative technologies to the clinic, developing the clinical and scientific evidence for adoption in routine care, such as the Clinspec Dx spectroscopic liquid biopsy test that can both stratify tumour risk in a symptomatic patient population, and predict tumour phenotype.
He is part of the CRUK Adult Brain Tumour Centre of Excellence, based on Edinburgh.
Paul’s research focus includes:
- Speeding up the diagnosis of brain tumours using symptom-based referral pathways and novel blood tests.
- Developing novel strategies for delivering chemotherapy focally in management of brain tumours. In collaboration with Dr Unciti-Broceta he is developing a palladium activated prodrug where the palladium catalyst will be implanted in the brain at surgery, better targeting drug activation.
- Understanding the cellular and molecular biology of the malignant transformation of low grade glioma.
- Since 2014 Paul has been working with Professor Sir Graham Teasdale, co-developer of the Glasgow Coma Scale, on a number of projects to enhance the use of the GCS, which is already the most widely used tool for assessment of consciousness in the world. Along with Professor Gordon Murray, Paul and Sir Graham published two papers in 2018 that introduced 1) a new scale to complement the GCS, the GCS Pupils Score, providing a rapid assessment of patient prognosis, and 2) the GCS prognostic charts for enhancing prognostication on the clinic. Data science underpins both projects. www.glasgowcomascale.org
He has an active involvement in clinical research and is co-applicant on a number of multi-centre studies. He was co-founder of the British Neurosurgical Trainee Research Collaborative that he helped found as Chair of the British Neurosurgical Trainees Association in 2012. He has led a UK collaborative study on management of chronic subdural haematoma and is interested in optimising the peri-operative care of these patients.
Complementing his clinical work, Paul founded eoSurgical Ltd in 2012 along with co-founders Roland Partridge and Mark Hughes. The University spin-out now provides surgical simulation training around the world.
In 2014 Paul helped in the foundation of the Compassion Initiative at the University of Edinburgh and is a co-Director, working in close collaboration with Prof Jim Doty's Centre for Compassion and Altruism Research at the University of Stanford.
Paul was a member of the Young Academy of Scotland and was co-chair between September 2015 and August 2017.
-
Development of prediction models for one-year brain tumour survival using machine learning: a comparison of accuracy and interpretability
In:
Computer methods and programs in biomedicine, vol. 233
DOI: https://doi.org/10.1016/j.cmpb.2023.107482
Research output: Contribution to Journal › Article (Published) -
Liquid biopsies: the future of cancer early detection
In:
Journal of translational medicine, vol. 21
DOI: https://doi.org/10.1186/s12967-023-03960-8
Research output: Contribution to Journal › Review article (Published) -
Screening for
in vitro
systematic reviews: a comparison of screening methods and training of a machine learning classifier
In:
Clinical science
DOI: https://doi.org/10.1042/CS20220594
Research output: Contribution to Journal › Article (E-pub ahead of print) -
Oncogene expression from extrachromosomal DNA is driven by copy number amplification and does not require spatial clustering in glioblastoma stem cells
In:
eLIFE, vol. 11
DOI: https://doi.org/10.7554/eLife.80207
Research output: Contribution to Journal › Article (Published) -
The future of brain tumor liquid biopsies in the clinic
In:
Neuro-Oncology Advances, vol. 4, pp. ii4-ii5
DOI: https://doi.org/10.1093/noajnl/vdac091
Research output: Contribution to Journal › Article (Published)